Alsace Business Angels
VC Fund
Illkirch-graffenstaden, France
Alsace Business Angels is a VC fund in Illkirch-graffenstaden focused on Biotechnology and Health Care. Alsace business angels: the winning momentum! Business angels are individuals who invest a portion of their personal assets in companies with strong growth potential and in addition make available to them their skills, experience and network of relationships.
- Total investments:
- 31
- Last investment:
- Lead investor:
- 42%
- Fund size:
- $850k
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Alsace Business Angels invests in
Stages Alsace Business Angels invests in
Countries Alsace Business Angels invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Biotechnology 8 (26%)
- Health Care 6 (19%)
- Software 5 (16%)
- Life Science 4 (13%)
- Medical 3 (10%)
Stage
- Seed 17 (55%)
- Funding Round 5 (16%)
- Series A 4 (13%)
- Pre-Seed 2 (6%)
- Angel 1 (3%)
Country
- France 24 (77%)
- United States 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Alain Aouizerats
President
|
President | Total investments: 0 | Find email | |
|
Jean-Sébastien Schmitt
representative
|
representative | Total investments: 1 | Find email | |
Sébastien Derivaux
Investor
|
Investor | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| ALBUPAD uses cutting-edge, environmentally friendly technology to create novel materials made entirely of proteins for use in biomedical applications. | $1.5M / Pre-Seed / Mar 03, 2026 | ||
| All In Box is a comprehensive client data collection and management platform designed specifically for local businesses and retailers, helping them capture, organize, and leverage customer information to enhance engagement, drive personalized marketing, and improve overall operational efficiency. | $1.2M / Seed / Sep 26, 2025 | ||
| StemInov is a biotechnology company that focuses on the development of stem cell therapies for inflammatory diseases. The company's primary focus is on critical care, specifically septic shock and Acute Respiratory Distress Syndrome (ARDS). StemInov's approach is based on robust preclinical data and widely accepted safety measures. Thecompany is developing an off-the-shelf and allogenic cell therapy. StemInov is also working on a drug-based therapy using mesenchymatous stem cells from Wharton's jelly (WJ-MSC). | $12.4M / Series A / Sep 25, 2025 | ||
| Entoinnov provides insect-based bioprocess converts agricultural by-products into superfood ingredients for humans and animals. | $1.7M / Seed / Oct 02, 2024 | ||
| C & Dac is a food company that research and develops new food products and meet sustainable food. | $1.8M / Oct 01, 2024 | ||
| Pass Interim is a platform connecting temporary employment professionals and job seekers, offering an easy-to-use solution for agencies to access profiles and allowing job seekers to register in just 3 minutes. | $650K / Seed / Jul 10, 2024 | ||
| Odimma is a biotech company that focuses on precision medicine and cure for personalized cancer immunotherapy. | $2M / Seed / Apr 13, 2023 | ||
| Miraxess turns your Smartphone into a Laptop. As people increasingly depend on their smartphones to organize their personal lives, it is becoming evident that the traditional computer has been replaced by the smartphone as the main servant of our digital needs. Miraxess introduces the Mirabook, a laptop extension for Smartphones. Plug in your Phoneand unleash the real power of the computer held in your hand to increase your productivity and comfort for work or entertainment. | $2.7M / Jan 05, 2023 | ||
| Miraxess turns your Smartphone into a Laptop. As people increasingly depend on their smartphones to organize their personal lives, it is becoming evident that the traditional computer has been replaced by the smartphone as the main servant of our digital needs. Miraxess introduces the Mirabook, a laptop extension for Smartphones. Plug in your Phoneand unleash the real power of the computer held in your hand to increase your productivity and comfort for work or entertainment. | $2.6M / Series A / Jan 05, 2023 | ||
| SPARTHA Medical develops invisible, eco-friendly, personalized and biocompatible coatings addressed to medical devices and consumer products to protect users from microbial and inflammatory risks.Our innovation stands on natural biopolymers which supramolecular assembly confers antibacterial, antiviral and anti-inflammatory properties to anysurface. We work basically with two different polyelectrolytes that do not need any further chemical procedure than mix to be effective. We can control the way they assemble (patented technology) to confer the versatile and multifunctional property we want to address depending on the field of work. | $1.6M / Seed / Dec 08, 2021 | ||
| See all 31 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Alsace Business Angels invest in?
Alsace Business Angels invests primarily in Biotechnology, Health Care and Software startups, most often at Seed and Funding Round stage. Most of the 31 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alsace Business Angels?
Public channels for Alsace Business Angels include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Alsace Business Angels?
The team at Alsace Business Angels includes Alain Aouizerats (President), Jean-Sébastien Schmitt (representative) and Sébastien Derivaux (Investor). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
